Physician Wealth Advisors Inc. Invests $92,000 in Unilever PLC (NYSE:UL)

Physician Wealth Advisors Inc. bought a new stake in Unilever PLC (NYSE:UL) during the fourth quarter, HoldingsChannel.com reports. The fund bought 1,627 shares of the company’s stock, valued at approximately $92,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. CIBC Private Wealth Group LLC raised its holdings in shares of Unilever by 22.7% in the 4th quarter. CIBC Private Wealth Group LLC now owns 73,077 shares of the company’s stock worth $4,103,000 after buying an additional 13,508 shares in the last quarter. Life Planning Partners Inc acquired a new position in Unilever during the fourth quarter worth $1,768,000. Portland Global Advisors LLC lifted its holdings in shares of Unilever by 1.1% during the fourth quarter. Portland Global Advisors LLC now owns 107,066 shares of the company’s stock valued at $6,071,000 after acquiring an additional 1,166 shares during the period. Transamerica Financial Advisors Inc. boosted its stake in shares of Unilever by 10.6% in the 4th quarter. Transamerica Financial Advisors Inc. now owns 4,703 shares of the company’s stock valued at $267,000 after purchasing an additional 449 shares in the last quarter. Finally, Intrust Bank NA grew its holdings in shares of Unilever by 13.2% in the 4th quarter. Intrust Bank NA now owns 25,258 shares of the company’s stock worth $1,432,000 after purchasing an additional 2,937 shares during the last quarter. Institutional investors own 9.67% of the company’s stock.

Unilever Stock Performance

NYSE UL opened at $59.18 on Monday. The stock has a market capitalization of $146.60 billion, a P/E ratio of 16.96, a price-to-earnings-growth ratio of 1.60 and a beta of 0.47. Unilever PLC has a 52 week low of $46.46 and a 52 week high of $65.87. The stock has a fifty day moving average of $57.61 and a 200-day moving average of $59.21.

Unilever Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Friday, February 28th were given a $0.4674 dividend. The ex-dividend date was Friday, February 28th. This represents a $1.87 dividend on an annualized basis and a yield of 3.16%. Unilever’s payout ratio is 53.01%.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Sanford C. Bernstein raised shares of Unilever from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 9th. DZ Bank upgraded Unilever from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. StockNews.com raised Unilever from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Finally, Royal Bank of Canada lowered Unilever from a “sector perform” rating to an “underperform” rating in a research note on Monday, January 6th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $66.33.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.